The contract identifies the intensive care units, the continuous monitoring units referred to in article R. 6123-38 and the paediatric continuous monitoring units referred to in article R. 6123-38-7 available to the establishment.
It identifies the structures applying systemic medicinal treatments for cancer under the conditions set out in article R. 6123-90-1.
It also identifies the treatments which are subject to national specifications and for which specific funding is provided.